ALKS

Alkermes plc News Headlines

$71.47
*  
1.22
1.74%
Get ALKS Alerts
*Delayed - data as of Mar. 2, 2015  -  Find a broker to begin trading ALKS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
What Most Alkerme Investors Really Want
10/14/2010 7:42:00 AM - Seeking Alpha


30 Stocks Showing Excessive Pessimism
8/11/2010 5:08:00 AM - Seeking Alpha


Dan Loeb's Hedge Fund Third Point Starts Multiple New Positions, Exits Citigroup
5/24/2010 5:25:00 PM - Seeking Alpha


Long and Short Ideas: Our Ninth Market Forecast Project Survey
4/23/2010 7:24:00 AM - Seeking Alpha


Amylin, Alkermes Find Relief in Benign FDA Response Letter to Diabetes Drug
3/16/2010 12:23:00 PM - Seeking Alpha


Equities Update: Buying a Late Bounce at Wal-Mart
3/15/2010 4:30:00 PM - Seeking Alpha


Has Amylin Hit a Top?
3/15/2010 12:43:00 PM - Seeking Alpha


Regulatory Catalyst News for ALKS, AMLN, LLY, MNKD, SVNT
3/15/2010 11:10:00 AM - Seeking Alpha


Byetta LARS: How the FDA's Analysis Paralysis May Aid Amylin
3/15/2010 6:09:00 AM - Seeking Alpha


Industry News Bytes: Delcath, Amylin and Access Pharma
3/14/2010 9:30:00 AM - Seeking Alpha


For Biotech in 2010, It's Déjà Vu All Over Again
3/8/2010 3:28:00 AM - Seeking Alpha


Dan Loeb's Third Point Likes Citigroup and Transdigm Group
2/22/2010 3:25:00 PM - Seeking Alpha